332 related articles for article (PubMed ID: 38356013)
1. Understanding the heterogeneity of anxiety using a translational neuroscience approach.
Drzewiecki CM; Fox AS
Cogn Affect Behav Neurosci; 2024 Apr; 24(2):228-245. PubMed ID: 38356013
[TBL] [Abstract][Full Text] [Related]
2. Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders.
Ressler KJ
Am J Psychiatry; 2020 Mar; 177(3):214-222. PubMed ID: 32114783
[TBL] [Abstract][Full Text] [Related]
3. Beyond Fear, Extinction, and Freezing: Strategies for Improving the Translational Value of Animal Conditioning Research.
Cain CK
Curr Top Behav Neurosci; 2023; 64():19-57. PubMed ID: 37532965
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology of Infant Fear and Anxiety: Impacts of Delayed Amygdala Development and Attachment Figure Quality.
Sullivan RM; Opendak M
Biol Psychiatry; 2021 Apr; 89(7):641-650. PubMed ID: 33109337
[TBL] [Abstract][Full Text] [Related]
5. Introduction to the special issue on the Neurobiology of Human Fear and Anxiety.
Fullana MA; Shackman AJ
Neurosci Biobehav Rev; 2023 Sep; 152():105308. PubMed ID: 37419231
[TBL] [Abstract][Full Text] [Related]
6. Context and trade-offs characterize real-world threat detection systems: A review and comprehensive framework to improve research practice and resolve the translational crisis.
Fendt M; Parsons MH; Apfelbach R; Carthey AJR; Dickman CR; Endres T; Frank ASK; Heinz DE; Jones ME; Kiyokawa Y; Kreutzmann JC; Roelofs K; Schneider M; Sulger J; Wotjak CT; Blumstein DT
Neurosci Biobehav Rev; 2020 Aug; 115():25-33. PubMed ID: 32439371
[TBL] [Abstract][Full Text] [Related]
7. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.
Bukalo O; Pinard CR; Holmes A
Br J Pharmacol; 2014 Oct; 171(20):4690-718. PubMed ID: 24835117
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and the Neurobiology of Temporally Uncertain Threat Anticipation.
Hur J; Smith JF; DeYoung KA; Anderson AS; Kuang J; Kim HC; Tillman RM; Kuhn M; Fox AS; Shackman AJ
J Neurosci; 2020 Oct; 40(41):7949-7964. PubMed ID: 32958570
[TBL] [Abstract][Full Text] [Related]
10. The nature and neurobiology of fear and anxiety: State of the science and opportunities for accelerating discovery.
Grogans SE; Bliss-Moreau E; Buss KA; Clark LA; Fox AS; Keltner D; Cowen AS; Kim JJ; Kragel PA; MacLeod C; Mobbs D; Naragon-Gainey K; Fullana MA; Shackman AJ
Neurosci Biobehav Rev; 2023 Aug; 151():105237. PubMed ID: 37209932
[TBL] [Abstract][Full Text] [Related]
11. The study of fear extinction: implications for anxiety disorders.
Graham BM; Milad MR
Am J Psychiatry; 2011 Dec; 168(12):1255-65. PubMed ID: 21865528
[TBL] [Abstract][Full Text] [Related]
12. Learning About Safety: Conditioned Inhibition as a Novel Approach to Fear Reduction Targeting the Developing Brain.
Odriozola P; Gee DG
Am J Psychiatry; 2021 Feb; 178(2):136-155. PubMed ID: 33167673
[TBL] [Abstract][Full Text] [Related]
13. Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework.
LeDoux JE; Pine DS
Am J Psychiatry; 2016 Nov; 173(11):1083-1093. PubMed ID: 27609244
[TBL] [Abstract][Full Text] [Related]
14. Fear attenuation collaborations to optimize translation.
Monfils MH; Lee HJ; Raskin M; Niv Y; Shumake J; Telch MJ; Smits JAJ; Otto MW
Behav Neurosci; 2024 Jun; 138(3):152-163. PubMed ID: 38934919
[TBL] [Abstract][Full Text] [Related]
15. Device-based brain stimulation to augment fear extinction: implications for PTSD treatment and beyond.
Marin MF; Camprodon JA; Dougherty DD; Milad MR
Depress Anxiety; 2014 Apr; 31(4):269-78. PubMed ID: 24634247
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging studies of amygdala function in anxiety disorders.
Rauch SL; Shin LM; Wright CI
Ann N Y Acad Sci; 2003 Apr; 985():389-410. PubMed ID: 12724173
[TBL] [Abstract][Full Text] [Related]
17. A behavioural neuroscience perspective on the aetiology and treatment of anxiety disorders.
Kindt M
Behav Res Ther; 2014 Nov; 62():24-36. PubMed ID: 25261887
[TBL] [Abstract][Full Text] [Related]
18. From the neurobiology of extinction to improved clinical treatments.
Morrison FG; Ressler KJ
Depress Anxiety; 2014 Apr; 31(4):279-90. PubMed ID: 24254958
[TBL] [Abstract][Full Text] [Related]
19. Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences.
Grillon C; Robinson OJ; Cornwell B; Ernst M
Neuropsychopharmacology; 2019 Nov; 44(12):1999-2010. PubMed ID: 31226707
[TBL] [Abstract][Full Text] [Related]
20. Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety.
Pine DS; Helfinstein SM; Bar-Haim Y; Nelson E; Fox NA
Neuropsychopharmacology; 2009 Jan; 34(1):213-28. PubMed ID: 18754004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
